Mode
Text Size
Log in / Sign up

A new tool improves accuracy and speed for spotting heart risks in patients with cardiomyopathy.

Share
A new tool improves accuracy and speed for spotting heart risks in patients with cardiomyopathy.
Photo by CDC / Unsplash

Researchers looked at how well a new imaging tool called VISTAQ works compared to standard methods for analyzing heart scans. This review examined data from 400 patients, including those with hypertrophic cardiomyopathy, prior heart attacks, and other non-ischemic heart diseases. The scans were reviewed at multiple centers using different equipment. The main goal was to see if the new tool could reliably find scar tissue that predicts future heart problems.

The new method showed very high agreement between different readers, with scores up to 0.98. It also reduced differences between observers, with the average difference dropping to just 1.3%. Most importantly, the analysis took much less time, averaging 105 seconds compared to 375 seconds with older methods. This speed difference was statistically significant.

When predicting heart events, the new tool found scar tissue in over 10% of cases with high accuracy. It correctly identified events with an AUC of 0.90, compared to 0.75 for older methods. The tool also had high sensitivity and specificity. No safety issues were reported because this was a review of imaging data, not a clinical trial. Readers should note this is a retrospective study, meaning it looks back at past data. While promising, more research is needed to confirm these results in broader settings.

What this means for you:
A new imaging tool may help doctors find heart risks faster and more accurately in patients with certain heart conditions.
Share
More on Myocardial Infarction